(Z)-SU14813
目录号: A15250
VEGFR 抑制剂
SU14813 是一种口服的多靶点酪氨酸激酶抑制剂(TKI),针对的靶点包括血管内皮生长因子受体(VEGFR)、血小板衍生生长因子受体(PDGFR)、Kit 和类似骨髓细胞增生性酪氨酸激酶 3(FLT-3)。
Discription | SU14813 is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), Kit, and fms-like tyrosine kinase 3 (FLT-3). |
---|
目录号 | A15250 |
---|---|
分子式 | C23H27FN4O4 |
分子量 | 442.48 |
CAS号 | 452105-23-6 |
SMILES | CC1=C(NC(=C1C(=O)NCC(CN2CCOCC2)O)C)C=C3C4=C(C=CC(=C4)F)NC3=O |
其他名称 | SU-14813, SU 14813 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2